The TNF-α system: Functional aspects in depression, narcolepsy and psychopharmacology

Current Neuropharmacology

Volumn 6, Issue 3, 2008, Pages 193-202

  Berthold Losleben, Mark ^a   Himmerich, Hubertus ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Antidepressant; Antipsychotic; Depression; TNF receptor; TNF

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOZAPINE; ETANERCEPT; GASTROINTESTINAL HORMONE; GHRELIN; HALOPERIDOL; INDOLEAMINE 2,3 DIOXYGENASE; LITHIUM; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PLACEBO; PROTEIN P75; PSYCHOTROPIC AGENT; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VENLAFAXINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; DEGENERATIVE DISEASE; DEPRESSION; DISEASE ASSOCIATION; DRUG MECHANISM; ENZYME BLOOD LEVEL; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREGULATION; MENTAL DISEASE; MULTIPLE SCLEROSIS; NARCOLEPSY; NEUROBIOLOGY; NEUROENDOCRINOLOGY; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSORIASIS; PSYCHOPHARMACOLOGY; REMISSION; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; WEIGHT CHANGE; WEIGHT GAIN;

EID: 53249093991     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015908785777238     Document Type: Review

References (118)

1. Alikhani, M., Alikhani, Z., Raptis, M., Graves, D.T.J. (2004) TNF-alpha in vivo stimulates apoptosis in fibroblasts through caspase-8 activation and modulates the expression of pro-apoptotic genes. Cell Physiol., 201, 341-348.
2. Antonarakis, S.E., Blouin, J.L., Pulver, A.E., Wolyniec, P., Lasseter, V.K., Nestadt, G., Kasch, L., Babb, R., Kazazian, H.H., Dombroski, B. et al. (1995) Schizophrenia susceptibility and chromosome 6p24-22. Nat. Genet., 11, 235-236.
3. Arzt, E., Kovalovsky, D. Igaz, L.M., Costas, M., Plazas, P., Refojo, D., Páez-Pereda, M., Reul, J.M., Stalla, G., Holsboer, F. (2000) Functional cross-talk among cytokines, T-cell receptor, and glucocorticoid receptor transcriptional activity and action. Ann. N. Y. Acad. Sci., 917, 672-677.
4. Baptista, T., Kin, N.M., Beaulieu, S., de Baptista, E.A. (2002) Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Pharmacopsychiatry, 35, 205-219.
5. Bastard, J.P., Maachi, M., Lagathu, C., Kim, M.J., Caron, M., Vidal, H., Capeau, J., Feve, B. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Network, 17, 4-12.
6. Besedovsky, H.O., del Rey, A. (2000) The cytokine-HPA axis feed-back circuit. Z. Rheumatol., 59(Suppl 2), 26-30.
7. Brustolim, D., Ribeiro-dos-Santos, R., Kast, R.E., Altschuler, E.L., Scares, M.B. (2006) A new chapter opens in anti-inflammatory treatments: the antidepressant Impropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int. Immunopharmacol., 6, 903-907.
8. Carlini, V.P., Gaydou, R.C., Schiöth, H.B., de Barioglio, S.R. (2007) Selective serotonin reuptake inhibitor (fluoxetine) decreases the effects of ghrelin on memory retention and food intake. Regul. Pept., 140, 65-73.
9. Carswell, E.A., Old, L.J., Kassel, R.L., Green, S., Fiore, N., Williamson B. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72, 3666-3670.
10. Choi, I., Kang, H.S., Yang, Y., Pyun, K.H. (1994) IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin. Exp. Immunol., 95, 530-535.
11. Churchill, L., Taishi, P., Wang, M., Brandt J., Cearley, C., Rehman, A., Krueger, J.M. (2006) Brain distribution of cytokine mRNA induced by systemic administration of interleukin-1beta or tumor necrosis factor alpha, Brain Res., 1120, 64-73.
12. Clark, I.A. (2007) How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev., 18, 335-343.
13. Conti, B., Tabarean, I., Andrei, C., Bartfai, T. (2004) Cytokines and fever. Front. Biosci., 9, 1433-1449.
14. Cummings, D.E., Shannon, M.H. (2003) Roles for gbrelin in the regulation of appetite and body weight. Arch. Surg., 138, 389-396.
15. Dantzer, R. (2001) Cytokine-Induced Sickness Behavior: Mechanisms and Implications. Ann. N. Y. Acad. Sci., 933, 222-234.
16. Dauvilliers, Y. (2003) Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy. Rev. Neurol., 159 (Suppl 11), 83-87.
17. Davis, M. (1991) Hepatotoxicity of antidepressants. Int. Clin. Psychopharmacol., 6, 97-103.
18. Fiers, W. (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett., 285, 199-212.
19. Fricchione, G., Daly, R., Rogers, M.P., Stefano, G.B. (2001) Neuroimmunologic influences in neuropsychiatric and psychophysiologic disorders. Acta. Pharmacol. Sin., 22, 577-587.
20. Glossop, J.R., Dawes, P.T., Nixon, N.B., Mattey, D.L. (2005) Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Arthritis Res. Ther., 7, 1227-1234.
21. Goodsell, D.S. (2006) The molecular perspective: tumor necrosis factor. Oncologist, 11, 83-84.
22. Guneli, E., Kazikdas, K.C., Kolatan, E. (2007) Ghrelin may attenuate proinflammatory cytokine-mediated neuropathic pain. Med. Hypotheses, 69, 356-360.
23. Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kuhn, M., Schuld, A., Pollmächer, T. (1999) Plasma levels of cytokines and soluble cytokine nceptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J. Psychiatr. Res., 33, 407-418.
24. Harlan, J., Chen, Y., Gubbins, E., Mueller, R., Roch, J.M., Walter, K., Lake, M., Olsen, T., Metzger, P., Derwin, S., Ladror, U., Egan, D.A., Severin, J., Johnson, R.W., Holzman, T.F., Voelp, K., Davenport, C., Beck, A., Potter, J., Gopalakrishnan, M., Hahn, A., Spear, B.B., Halbert, D.N., Sullivan, J.P., Abkevich, V., Neff, C.D., Skolnick, M.H., Shattuck, D., Katz, D.A. (2006) Variants in Apaf-1 segregating with major depression promote apoptosome function. Mol. Psychiatry, 11, 76-85.
25. Harris, T.B., Ferrucci, L., Tracy, R.P., Corti, M.C., Wacholder, S., Ettinger Jr., W.H., Heimovitz, H., Cohen, H.J., Wallace, R. (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med., 106, 506-512.
26. Himmerich, H. (2007) Activity of the TNF-α system in patients with brain disorders and during psychopharmacological treatment. Curr. Pharmaceut, Anal., 3, 1-5.
27. Himmerich, H. (2008) Metabolic and neuroendocrine aspects of the TNF-α system during psychiatric disorders and psychopharmacological treatment. In: Romano, E., De Luca, S. Eds, New Research on Neurosecretory Systems. New York, Nova Science Publishers. (in press).
28. Himmerich, H., Beitinger, P.A., Fulda, S., Wehrle, R., Linseisen, J., Wolfram, G., Himmerich, S., Gedrich, K., Wetter, T.C., Pollmiächer, T. (2006) Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy. Arch. Intern. Med., 166, 1739-1743.
29. Himmerich, H., Binder, E.B., Künzel, H.E., Schuld, A., Lucae, S., Uhr, M., Pollmächer, T., Holsboer, F., Ising, M. (2006) Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol. Psychiatry, 60, 882-888.
30. Himmerich, H., Fulda, S., Künzel, H.E., Pfennig, A., Dzaja, A., Cummings, D.E., Pollmächer, T. (2005) Ghrelin plasma levels during psychopharmacological treatment. Neuropsychobiology, 52, 11-16.
31. Himmerich, H., Fulda, S., Linseisen, J., Seiler, H., Wolfram, G., Himmerich, S., Gedrich, K., Pollmächer, T. (2006) TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur. Cytokine Network, 17, 196-201.
32. Himmerich, H., Kaufmann, C., Schuld, A., Pollmächer, T. (2005) Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain. J. Psychiatr. Res., 39, 35-42.
33. Himmerich, H., Koethe, D., Schuld, A., Yassouridis, A., Pollmächer, T. (2005) Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology, 179, 447-451.
34. Himmerich, H., Schuld, A., Haack, M., Kaufmann, C., Pollmächer, T. (2004) Early prediction of changes in weight during six weeks of treatment with antidepressants. J. Psychiatr. Res., 38, 485-489.
35. Hinze-Selch, D., Deuschle, M., Weber, B., Heuser, I., Pollmächer T. (2000) Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight. Psychopharmacology, 149, 163-169.
36. Hinze-Selch, D., Schuld, A., Kraus, T., Kühn, M., Uhr, M., Haack, M., Pollmächer, T. (2000) Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology, 23, 13-19.
37. Hohjoh, H., Nakayama, T., Ohashi, J., Miyagawa, T., Tanaka, H., Akaza, T., Honda, Y., Tokunaga, K. (1999) Significant association of a single micleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens, 54, 138-145.
38. Hornig, M., Lipkin, W.I. (2001) Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses, and animal models. Ment. Retard. Dev. Disabil. Res. Rev., 7, 200-210.
39. Hoshi, T., Kitagawa, K., Yamagami, H., Furukado, S., Hougaku, H., Hori, M. (2005) Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke, 36, 768-772.
40. Ikejima, K., Takei, Y., Honda, H., Hirose, M., Yoshikawa, M., Zhang, Y.J., Lang, T., Fukuda, T., Yamashina, S., Kitamura, T., Sato, N. (2002) Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology, 122, 1399-1410.
41. Jenny, N.S., Tracy, R.P., Ogg, M.S., Luong, A., Kuller, L.H., Arnold, A.M., Sharrett, A.R., Humphries, S.E. (2002) In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol., 22, 2066-2071.
42. Kapcala, L.P., Chautard, T., Eskay, R.L. (1995) The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious, and inflammatory stress. Ann. N. Y. Acad. Sci., 771, 419-437.
43. Karni, A., Abraham, M., Monsonego, A., Cai, G., Freeman, G.J., Hafler, D., Khoury, S.J., Weiner, H.L. (2006) Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol., 177, 4196-4202.
44. Kraus, T., Haack, M., Schuld, A., Hinze-Selch, D., Koethe, D., Pollmächer, T. (2002) Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiaty, 35, 220-225.
45. Kraus, T., Haack, M., Schuld, A., Hinze-Selch, D., Kühn, M., Uhr, M., Pollmächer, T. (1999) Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am. J. Psychiatry, 156, 312-314.
46. Ledeen, R.W., Chakraborty, G. (1998) Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis. Neurochem. Res., 23, 277-289.
47. van der Lely, A.J., Tschop, M., Heiman, M.L., Ghigo, E. (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev., 25, 426-457.
48. Lin, L., Hungs, M., Mignot, E. (2001) Narcolepsy and the HLA region. J. Neuroimmunol., 117, 9-20.
49. Lindholm, E., Ekholm, B., Balciuniene, J., Johansson, G., Castensson, A., Koisti, M., Nylander, P.O., Pettersson, U., Adolfsson, R., Jazin, E. (1999) Linkage analysis of a large Swedish kindred provides further support for a susceptibility locus for schizophrenia on chromosome 6p23. Am. J. Med. Genet., 88, 369-377.
50. Linthorst, A.C., Rcul, J.M. (1999) Inflammation and bran function under basal conditions and during long-term elevation of brain corticotropin-releasing hormone levels. Adv. Exp. Med. Biol., 461, 129-152.
51. Maes, M., Scharpé, S., Meltzer, H.Y., Bosmans, E., Suy, E., Calabrese, J., Cosyns, P. (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res., 49, 11-27.
52. Maes, M., Song, C., Lin, A.H., Bonaccorso, S., Kenis, G., De Jongh, R., Bosmans, E., Scharpe, S. (1999) Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology, 20, 370-379.
53. Maes, M., Song, C., Lin, A.H., Pioli, R., Kenis, G., Kubera, M., Bosmans, E. (1999) In vitro immunoregulatory effects of lithium in healthy volunteers. Psychopharmacology, 143, 401-407.
54. Merrill, J.E. (1992) Proinflammatory and anti-inflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunother., 12, 167-170.
55. Michie, H.R., Spriggs, D.R., Manogue, K.R., Sherman, M.L., Revhaug, A., O'Dwyer, S.T., Arthur, K., Dinarello, C.A., Cerami, A., Wolff, S.M., Wilmom, D.W. (1988) Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery, 104, 280-286.
56. Mignot, E., Tafti, M., Dement W.C., Grumet, F.C. (1995) Narcolepsy and immunity. Adv. Neuroimmunol., 5, 23-37.
57. Möller, E., Böhme, J., Valugerdi, M.A., Ridderstad, A., Olerup, O. (1990) Speculations on mechanisms of HLA associations with autoinimune diseases and the specificity of "autoreactive" T lymphocytes. Immunol. Rev., 118, 5-19.
58. Murashita, M., Kusumi, I., Hosoda, H., Kangawa, K., Koyama, T. (2007) Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats. Psychoneuroendocrinology, 32, 777-784.
59. Murashita, M., Kusumi, I., Inoue, T., Takahashi, Y., Hosoda, H., Kangawa, K., Koyama, T. (2005) Olanzapinc increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology, 30, 106-110.
60. Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., Matsukura, S. (2001) A role for ghrelin in the central regulation of feeding. Nature, 409, 194-198.
61. Newton, J.R. (2007) Linked gene ontology categories are novel and differ from associated gene ontology categories for the bipolar disorders. Psychiatr. Genet., 17, 29-34.
62. Nishino, S., Kanbayashi, T. (2005) Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/ orexin system. Sleep Med Rev., 9, 269-310.
63. O'Brien, S.M., Scott, L.V., Dinan, T.G. (2004) Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum. Psychopharmacol., 19, 397-403.
64. Panagiotakos, D.B., Pitsavos, C., Yannakoulia, M., Chrysohoou, C., Stefanadis, C. (2005) The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis, 183, 308-315.
65. Park, H.S., Park, J.Y., Yu, R. (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract., 69, 29-35.
66. Pedersen, M., Bruunsgaard, H., Weis, N., Hendel, H.W., Andreassen, B.U., Eldrup, E., Dela, F., Pedersen, B.K. (2003) Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech. Ageing Dev., 124, 495-502.
67. Perskidskii, IuV., Barshtein, IuA. (1992) Biological manifestations of the tumor necrosis factor effect and its role in the pathogenesis of various diseases. Arkh. Patol., 54, 5-10.
68. Pessayre, D., Berson, A., Fromenty, B., Mansouri, A. (2001) Mitochondria in-steatohepatitis. Semin. Liver Dis., 21, 57-69.
69. Petrovsky, N., McNair, P., Harrison L.C. (1998) Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine, 10, 307-312.
70. Pickering, M., Cumiskey, D., O'Connor, J.J. (2005) Actions of TNF-α on glutamatergic synaptic transmission in the central nervous system. Exp. Physiol., 90, 663-670.
71. Plata-Salamán, C.R. (1999) 1998 Curt P. Richter Award. Brain mechanisms in cytokine-induced anorexia. Psychoneuroendocrinology, 24, 25-41.
72. Plumpe, J., Malek, N.K., Bock, C.T., Rakemann, T., Manns, M.P., Trautwein, C. (2000) NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol., 278, 173-183.
73. Pollmächer, T., Haack, M., Schuld, A., Kraus, T., Hinze-Selch, D. (2000) Effects of antipsychotic drugs on cytokine networks. J. Psychiatr. Res., 34, 369-382.
74. Pollmächer, T., Hinze-Selch, D., Fenzel, T., Kraus, T., Schuld, A., Mullington, J. (1997) Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am. J. Psychiatry, 154, 1763-1765.
75. Pollmächer, T., Hinze-Selch, D., Mullington, J. (1996) Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J. Clin. Psychopharmacol., 16, 403-409.
76. Pucak, M.L., Kaplin, A.I. (2005) Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression. Int. Rev. Psychiatry, 17, 477-483.
77. Reddy, P., Slack, J.L., Davis, R., Cerretti, D.P., Kozlosky, C.J., Blanton, R.A., Shows, D., Peschon, J.J., Black, R.A.J. (2000) Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. Biol. Chem., 275, 14608-14614.
78. Reichenberg, A., Kraus, T., Haack, M., Schuld, A., Pollmächer, T., Yirmiya, R. (2002) Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion. Psychoneuroendocrinology, 27, 945-956.
79. Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., Pollmächer, T. (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen. Psychiatry, 58, 445-452.
80. Reul, J.M., Labeur, M.S., Wiegers, G.J., Linthorst, A.C. (1998) Altered neuroimmunoendocrine communication during a condition of chronically increased brain corticotropin-releasing hormone drive. Ann. N. Y. Acad. Sci., 840, 444-455.
81. Ridker, P.M., Rifai, N., Stampfer, M.J., Hennekens, C.H. (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 101, 1767-1772.
82. Roerig, J.L., Steffen, K.J., Mitchell, J.E., Crosby, R.D., Gosnell, B.A. (2008) A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels. J. Clin. Psychopharmacol., 28, 21-26.
83. Schmid, D.A., Wichniak, A., Uhr, M., Ising, M., Brunner, H., Held, K., Weikel, J.C., Sonntag, A., Steiger, A. (2006) Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neurapsychopharmacology, 31, 832-844.
84. Schöbitz, B., Reul, J.M., Holsboer, F. (1994) The role of the bypothalamic-pituitary-adrenocortical system during inflammatory conditions. Crit. Rev. Neurobiol., 8, 269-291.
85. Schuld, A., Kraus, T., Haack, M., Hinze-Selch, D., Kühn, M., Pollmächer, T. (2000) Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophr. Res., 102, 1-3.
86. Schuld, A., Schmid, D.A., Haack, M., Holsboer, F., Friess, E., Pollmächer, T. (2003) Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone. J. Psychiatr. Res., 37, 463-470.
87. Schwab, S.G., Albus, M., Hallmayer, J., Honig, S., Borrmann, M., Lichtermann, D., Ebstein, R.P., Ackenheil, M., Lerer, B., Risch, N., et al. (1995) Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat. Genet., 11, 325-327.
88. Selim, K., Kaplowitz, N. (1999) Hepatotoxicity of psychotropic drugs. Hepatology, 29, 1347-1351.
89. Silverman, M.N., Pearce, B.D., Biron, C.A., Miller, A.H. (2005) Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol., 18, 41-78.
90. Sorge, S. (2003) Der Einfluss des atypischen Neuroleptikums Clozapin auf das Verhalten und das Immunsystem der Ratte. Dissertationsschrift. München. Technische Universität München.
91. Spies, T., Morton, C.C., Nedospasov, S.A., Fiers, W., Pious, D., Strominger, J.L. (1986) Genes for the tumor necrosis factors alpha and beta are linked to human major histocompatibility complex. Proc. Natl. Acad. Sci. USA, 83, 8699-8702.
92. Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., Suzumura, A. (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem., 281, 21362-21368.
93. Tanabe, A., Nomura, S. (2007) Pathophysiology of depression. Nippon Rinsho, 65, 1585-1590.
94. Thannickal, T.C., Moore, R.Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., Siegel, J.M. (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron, 27, 469-474.
95. Theisen, F.M., Gebhardt, S., Brömel, T., Otto, B., Heldwein, W., Heinzel-Gutenbrunner, M., Krieg, J.C., Remschmidt, H., Tschöp, M., Hebebrand, J. (2005) A prospective study of serum ghrelin levels in patients treated with clozapine. J. Neural. Transm., 112, 1411-1416.
96. Tilders, F.J., DeRijk, R.H., Van Dam, A.M., Vincent, V.A., Schotanus, K., Persoons, J.H. (1994) Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology, 19, 209-232.
97. Tilg, H. (2001) Cytokines and liver diseases. Can. J. Gastroenterol., 15, 661-668.
98. Tschöp M, Smiley, DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature, 407, 908-913.
99. Tschöp M, Weyer, C, Tataranni, PA, Devanarayan, V, Ravussin, E, Heiman, ML (2001) Circulating ghrelin levels are dcreased in human obesity. Diabetes, 50, 707-709.
100. Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., Cella, D., Krishnan, R. (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet, 367, 29-35.
101. Wajant, H., Pfizenmaier, K., Scheurich, P. (2003) Tumor necrosis factor signaling. P. Cell Death Differ., 10, 45-65.
102. Waje-Andreassen, U., Krakenes, J., Ulvestad, E., Thomassen, L., Myhr, K.M., Aarseth, J., Vedeler, C.A. (2005) IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol. Scand., 111, 360-365.
103. Wang, S., Sun, C.E., Walczak, C.A., Ziegle, J.S., Kipps, B.R., Goldin, L.R., Diehl, S.R. (1995) Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat. Genet., 10, 41-46.
104. Waseem, T., Duxbury, M., Ito, H., Ashley, S.W., Robinson, M.K. (2008) Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery, 143(3), 334-342.
105. Weinberger, D.R., Lipska, B.K. (1995) Cortical maldevelopment, antipsychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res., 16(2), 87-110.
106. Wichers, M., Maes, M. (2002) The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int. J. Neuropsychopharmacol., 5, 375-88.
107. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O., Duff, G.W. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA, 94, 3195-3199.
108. Wren, A.M., Seal, L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei, M.A., Bloom, S.R. (2001) Grelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab., 86, 5992-5995.
109. Wren, A.M., Small, C.J., Abbott, C.R., Dhillo, W.S., Seal, L.J., Cohen, M.J., Batterham, R.L., Taheri, S., Stanley, S.A., Ghatei, M.A., Bloom, S.R. (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes, 50, 2540-2547.
110. Wu, R., Dong, W., Cui, X., Zhou, M., Simms, H.H., Ravikumar, T.S., Wang, P. (2007) Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann. Surg., 245, 480-496.
111. Wu, R., Dong, W., Zhou, M., Zhang, F., Marini, C.P., Ravikumar, T.S., Wang, P. (2007) Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am. J. Respir. Crit. Care Med., 176, 805-813.
112. Yirmiya, R. (1997) Behavioral and psychological effects of immune activation: implications for 'depression due to a general medical condition. Curr. Opin. Psychiatry, 10, 470-476.
113. Zai, G., Müller, D.J., Volavka, J., Czobor, P., Lieberman, J.A., Meltzer, H.Y., Kennedy, J.L. (2006) Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication. Psychopharmacology, 188, 171-182.
114. Zeyda, M., Farmer, D., Todoric, J., Aszmann, O., Speiser, M., Györi, G., Zlabinger, G.J., Stulnig, T.M. (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int. J. Obes., 31, 1420-1428.
115. Zhang, H., Yin, J., Li, D., Zhou, X, Li, X. (2007) Tryptophan enhances ghrelin expression and secretion associated with increased food intake and weight gain in weanling pigs. Domest. Anim. Endocrinol., 33, 47-61.
116. Zhang, M., Yuan, F., Chen, H., Qiu, X., Fang, W. (2007) Effect of exogenous ghrelin on cell differentiation antigen 40 expression in endothelial cells. Acta Biochim. Biophys. Sin., 39, 974-981.
117. Zhu, C.B., Blakely, R.D., Hewlett, W.A. (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychapharmacology, 31, 2121-2131.
118. Zimmermann, U., Kraus, T., Himmerich, H., Schuld, A., Pollmächer, T. (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J. Psychiatr. Res., 37, 193-220.